CLDN3 and inflammatory bowel disease: Knockout studies of Claudin genes result in loss of tight junction barrier function, with the dysregulation of Claudin-3 gene reported in IBD (both Crohn’s disease [39,40] and ulcerative colitis [41,42]) and celiac disease [43].